Advanced Accelerator Applications 20 rue Diesel 01630 SAINT GENIS POUILLY FRANKRIJK Fabrikant Advanced Accelerator Applica - 검색 결과

bracco suisse sa - strontium (82-sr) la calibrazione data - generator von radionukliden - strontium (82-sr) la calibrazione data 3.3-5.6 gbq, stanni(iv) oxidum, natrii chloridi solutio 9 g/l natrii hydroxidum, acidum hydrochloridum, pro vitro, natrium mg. - für pet - (positronen-emissions-tomographie) myokardinfarkt - generator

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

lutathera ca 370 mbq/ml infusionslösung

novartis pharma schweiz ag - lutetium(177-lu(ca)) oxodotreotidum - infusionslösung - lutetium(177lu(ca)) oxodotreotidum 370 mbq, acidum aceticum, natrii acetas, acidum penteticum, natrii chloridum, natrii hydroxidum, acidum gentisicum, e 300, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.24 mg. - gastroenteropankreatische neuroendokrine tumore (gep‑net) - radiopharmazeutika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

netspot 40 mcg kit für ein radioaktives arzneimittel

novartis pharma schweiz ag - oxodotreotidum - kit für ein radioaktives arzneimittel - i) durchstechflasche-1 lyophilisat: oxodotreotidum 40 µg, 1,10-phenanthrolinum, mannitolum, acidum gentisicum, pro vitro. ii) durchstechflasche-2 reaktionspuffer: acidum formicicum, natrii hydroxidum corresp. natrium 32.48 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - pet tomographie für neuroendokrine tumore (net), bei welchen die somatostatin-rezeptoren überexprimiert werden. - radiopharmazeutika

유럽 연합 - 독일어 - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastische mittel - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.